Analyst Price Targets — SGRY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 18, 2025 12:07 pm | — | Mizuho Securities | $19.00 | $15.80 | TheFly | Surgery Partners price target lowered to $19 from $22 at Mizuho |
| November 21, 2025 10:17 am | — | Barclays | $18.00 | $15.30 | TheFly | Surgery Partners price target lowered to $18 from $24 at Barclays |
| November 17, 2025 4:47 pm | — | Mizuho Securities | $22.00 | $15.20 | TheFly | Surgery Partners price target lowered to $22 from $28 at Mizuho |
| November 13, 2024 9:03 pm | Brian Tanquilut | Jefferies | $40.00 | $29.74 | StreetInsider | Surgery Partners (SGRY) PT Lowered to $40 at Jefferies |
| November 13, 2024 2:44 pm | Andrew Mok | Barclays | $31.00 | $29.74 | StreetInsider | Surgery Partners (SGRY) PT Lowered to $31 at Barclays |
| October 14, 2024 3:25 am | AJ Rice | UBS | $38.00 | $30.46 | StreetInsider | UBS Starts Surgery Partners (SGRY) at Buy |
| June 28, 2024 2:51 am | Tao Qiu | Macquarie | $31.00 | $24.32 | StreetInsider | Macquarie Starts Surgery Partners (SGRY) at Outperform |
| May 4, 2022 8:34 am | — | Citigroup | $64.00 | $53.62 | Benzinga | Citigroup Maintains Buy on Surgery Partners, Raises Price Target to $64 |
Latest News for SGRY
BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time).
Irenic Capital sold 1,047,583 shares of Surgery Partners in the fourth quarter; the estimated transaction value was $19.25 million based on average fourth-quarter pricing. The quarter-end position value decreased by $23.19 million, reflecting both share sales and price changes.
Surgery Partners (SGRY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Surgery Partners, Inc. (NASDAQ: SGRY - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the ten research firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the
Voya Investment Management LLC lessened its holdings in Surgery Partners, Inc. (NASDAQ: SGRY) by 86.5% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,842 shares of the company's stock after selling 88,405 shares during the period. Voya Investment Management
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SGRY.
U.S. House Trading
No House trades found for SGRY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.